CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 25 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,868 | -18.2% | 10,425 | -51.1% | 0.00% | -50.0% |
| Q2 2022 | $149,000 | -15.8% | 21,308 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $177,000 | +30.1% | 21,308 | +6.3% | 0.00% | 0.0% |
| Q4 2021 | $136,000 | +151.9% | 20,046 | -16.5% | 0.00% | -50.0% |
| Q1 2014 | $54,000 | -3.6% | 24,000 | -14.3% | 0.00% | 0.0% |
| Q4 2013 | $56,000 | -34.1% | 28,000 | 0.0% | 0.00% | -42.9% |
| Q3 2013 | $85,000 | – | 28,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |